Event Date
Mar 14
2023
CHAMPIONING CHOICE IN A MULTI-PRODUCT HIV PREVENTION MARKET
New products, including the dapivirine vaginal ring and injectable cabotegravir, have been approved in several countries, and more biomedical prevention products are in development. As the catalog of HIV prevention products expands, so too does the conversation about the importance of upholding choice to optimize the benefits for potential PrEP users.
Continue ReadingEvent Date
Dec 8
2022
PARENTS, PARTNERS, AND PEERS: THE ROLE OF INFLUENCERS IN ADOLESCENT GIRLS’ AND YOUNG WOMEN’S PrEP USE
We know that adolescent girls and young women live complex lives full of important relationships that shape the decisions they make. Yet too often efforts to generate demand for PrEP fail to reach beyond the individual user to her support system—those trusted people in her life who she leans on when making important choices. But demand generation for PrEP is evolving.
Continue ReadingEvent Date
Sep 8
2022
ARE WE THERE YET? PROGRESS AND PITFALLS WITH SCALING UP PrEP DELIVERY
Since oral PrEP was first approved for use in 2012, dozens of countries have approved the product and use is expanding. But the pace of scale-up has been slower than expected and PrEP remains out of reach for many who may benefit from it.
Continue ReadingEvent Date
Jul 31
2022
AIDS 2022 SCIENTIFIC WORKSHOP | OUR NEXT SHOT: EFFECTIVELY DELIVERING INJECTABLE CABOTEGRAVIR FOR PrEP
This workshop will explore what is needed to ensure that introductory research and programs are strategically designed, user-centered, and appropriately resourced to support successful rollout of CAB PrEP.
Continue ReadingEvent Date
Jun 2
2022
SHE DECIDES: SUPPORTING PrEP DECISION-MAKING AMONG ADOLESCENT GIRLS AND YOUNG WOMEN IN A MULTI-PRODUCT PrEP MARKET
As we move toward a multi-product HIV prevention market, adolescent girls and young women must be empowered to choose an HIV prevention product that meets their needs.
Continue Reading